| Patents for C07D 215 - Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems (27,676) |
|---|
| 02/27/2002 | EP1181269A1 Cell proliferation inhibitors |
| 02/27/2002 | EP1181267A1 Halogen compounds |
| 02/27/2002 | EP1181266A1 Squaric acid derivatives as cell adhesion molecules |
| 02/27/2002 | EP0945434B1 Process for producing halogenated heteroaryl compounds |
| 02/27/2002 | EP0587645B1 Benzo- and pyridopyran derivatives having anxiolytic and anti-convulsant activity |
| 02/27/2002 | CN1337962A Acetylenic ortho-sulfonamido and phosphinic acid amido bicyclic heteroaryl hydroxamic acids as TACE inhibitors |
| 02/27/2002 | CN1337950A 2-oxoquinoline compounds and medicinal uses thereof |
| 02/27/2002 | CN1337945A Alkynyl containing hydroxamic acid compounds as TACE inhibitors |
| 02/27/2002 | CN1079638C Fungicidal mixture |
| 02/26/2002 | US6350892 Trifluoromethyl ketone analogs as selective cPLA2 inhibitors |
| 02/26/2002 | US6350759 Dihydro- and tetrahydro-quinoline compounds |
| 02/26/2002 | US6350750 Quinoline and quinazoline derivatives having corticotropin releasing factor (CRF) antagonist activity |
| 02/26/2002 | US6350749 Aminoguanidine hydrazone derivatives, process for producing the same and drugs thereof |
| 02/21/2002 | WO2002014457A1 Lubricating compositions containing aromatized 1,2-dihydro-2,2,4-trimethylquinoline polymers |
| 02/21/2002 | WO2002014294A2 Heterocyclic sulfonamide derivatives and their use for potentiating glutamate receptor function |
| 02/21/2002 | WO2002014283A1 Processes for preparing cilostazol |
| 02/21/2002 | WO2002014275A2 Heterocyclic sulfonamide derivatives and their use for potentiating glutamate receptor function |
| 02/21/2002 | WO2002014269A2 2,4-substituted pyridine derivatives |
| 02/21/2002 | WO2002014267A1 Novel aminocyclohexane derivatives |
| 02/21/2002 | WO2002014244A1 Hydrocarbon compound, material for organic electroluminescent element and organic electroluminescent element |
| 02/21/2002 | WO2002013797A2 Therapeutic combination of a cetp inhibitor and atorvastatin |
| 02/21/2002 | CA2419406A1 Pharmaceutical combinations of torcetrapib and atorvastatin or hydroxy derivatives for the treatment of atherosclerosis, angina and low hdl levels |
| 02/21/2002 | CA2419181A1 Processes for preparing cilostazol |
| 02/21/2002 | CA2418853A1 2,4-substituted pyridine derivatives |
| 02/19/2002 | US6348627 Aryl and heteroarylcyclopropyl oxime ethers and their use as fungicides |
| 02/19/2002 | US6348482 Catechols as antimicrobial agents |
| 02/19/2002 | US6348474 Compounds as antidiabetic agents |
| 02/19/2002 | US6348463 Phenylalanine derivatives |
| 02/19/2002 | US6348462 Viricides |
| 02/14/2002 | WO2002012224A2 Bicyclic compounds as h3 receptor ligands |
| 02/14/2002 | WO2002012214A2 Non-imidazole aryloxyalkylamines as h3 receptor ligands |
| 02/14/2002 | WO2002012199A1 Heterocyclic mutilin esters and their use as antibacterials |
| 02/14/2002 | WO2002012192A1 Quinolene derivatives as anti-inflammation agents |
| 02/14/2002 | WO2002012190A2 Non-imidazole aryloxypiperidines as h3 receptor ligands |
| 02/14/2002 | WO2001051479A3 Tricyclic compounds with antiviral activity |
| 02/14/2002 | WO2001044324A3 Polymerization of olefins |
| 02/14/2002 | US20020019530 Antitumor agent |
| 02/14/2002 | US20020019416 Esters and amides as pla2 inhibitors |
| 02/14/2002 | US20020019414 N-aryl(thio)anthranilic acid amide derivatives, their preparation and their use as VEGF receptor tyrosine kinase inhibitors |
| 02/14/2002 | US20020019405 Nitrosated and nitrosylated phosphodiesterase inhibitors, compositions and methods of use |
| 02/14/2002 | US20020019397 Heterocycle carboxamides as antiviral agents |
| 02/14/2002 | US20020018912 Transistors, liquid crystal display, electrooptics |
| 02/14/2002 | CA2419036A1 Non-imidazole aryloxypiperidines as h3 receptor ligands |
| 02/14/2002 | CA2419027A1 Bicyclic compounds as h3 receptor ligands |
| 02/14/2002 | CA2418832A1 Quinolene derivatives as anti-inflammation agents |
| 02/14/2002 | CA2418369A1 Non-imidazole aryloxyalkylamines as h3 receptor ligands |
| 02/13/2002 | EP1178967A1 Quinoline derivatives as inhibitors of mek enzymes |
| 02/13/2002 | EP1178966A1 Quinoline derivatives as inhibitors of mek enzymes |
| 02/13/2002 | EP1178965A1 Quinoline derivatives as inhibitors of mek enzymes |
| 02/13/2002 | EP1178964A1 Substituted polycyclic aryl and heteroaryl pyridones useful for selective inhibition of the coagulation cascade |
| 02/13/2002 | EP1178959A1 Alpha-amino-beta-sulfonyl hydroxamic acid compounds |
| 02/13/2002 | EP1178958A2 N-cyanomethyl amides as protease inhibitors |
| 02/13/2002 | EP1178953A1 Aromatic amides |
| 02/13/2002 | CN1335301A 3-cyano-2,4,5-trifluoro-benzoic acid and its derivant and their application |
| 02/12/2002 | US6346532 Antidiabetic, antilipemic, and hypoglycemic agents; adrenergic stimulants |
| 02/12/2002 | CA2053705C Piperazine derivatives |
| 02/07/2002 | WO2002010177A1 Ammonium salts of inositol hexaphosphate and uses thereof |
| 02/07/2002 | WO2002010134A1 Process for asymmetric synthesis of substituted 1,4-dihydropyridines |
| 02/07/2002 | WO2002009758A2 Inhibitors of cellular efflux pumps of microbes |
| 02/07/2002 | WO2001030333A3 Tissue factor antagonists and methods of use thereof |
| 02/07/2002 | US20020016464 Sodium channel blockers used to treat amyotrophic lateral sclerosis; analgesics, anticonvulsants, antidepressants, local anesthetics and antiarrhythmics |
| 02/07/2002 | US20020016368 Administering to a mammal a therapeutically effective amount of a compound of sulfonamide or alkanoy or amide derivative containing hetero or aromatic rings to treat osteoporosis, osteotomy, childhood idiopathic boen loss etc. |
| 02/07/2002 | US20020016347 Benzophenones as inhibitors of IL-1beta and TNF-alpha |
| 02/07/2002 | US20020016336 Treatment of rheumatoid and osteoarthritis, corneal, epidermal or gastric ulceration, tumor metastasis or invasion, periodontal disease and bone disease |
| 02/07/2002 | US20020016320 Inhibiting beta-secretase enzyme activity and A beta peptide production. |
| 02/07/2002 | CA2417799A1 Inhibitors of cellular efflux pumps of microbes |
| 02/06/2002 | EP1177187A1 Di-aryl acid derivatives as ppar receptor ligands |
| 02/06/2002 | EP1177177A1 Substituted 4-oxo-quinoline-3-carboxamides: gaba brain receptor ligands |
| 02/06/2002 | EP1177176A1 Tri-aryl acid derivatives as ppar receptor ligands |
| 02/06/2002 | EP1177169A1 6- [(aryl and heteroaryl)oxy] methyl]naphthalene -2-carboximidamide derivatives, preparation and therapeutic application thereof |
| 02/06/2002 | EP1176958A1 Novel catechols as antimicrobial agents |
| 02/06/2002 | EP1176956A1 Carboxylic acid derivatives that inhibit the binding of integrins to their receptors |
| 02/05/2002 | US6344485 Method for treating glaucoma |
| 02/05/2002 | US6344463 Skin disorders, acne |
| 02/05/2002 | US6344462 Heterocyclic compounds as bradykinin antagonists |
| 02/05/2002 | CA2123403C Acyclic ethylenediamine derivatives as substance p receptor antagonists |
| 01/31/2002 | WO2002008192A1 Novel heteroaryl derivatives and the use thereof as pharmaceuticals |
| 01/31/2002 | WO2001021160A3 Carboxymide and aniline derivatives as selective inhibitors of pathogens |
| 01/31/2002 | WO2001014328A3 Substituted ureas as cell adhesion inhibitors |
| 01/31/2002 | US20020013468 Chemical intermediate for macrolactone antibiotic |
| 01/31/2002 | US20020013341 For therapy of acute infection, acute phase response, age related macular degeneration, alcoholism, anorexia, asthma, autoimmune disease, autoimmune hepatitis, Bechet's disease, cachexia, calcium pyrophosphate dihydrtate deposition |
| 01/31/2002 | US20020013317 For therapy and prophylaxis of psychotic disorders such as schizophrenia and other central nervous system disease |
| 01/30/2002 | EP1175417A1 Substituted benzolactam compounds |
| 01/30/2002 | EP1175404A1 Quinazolinone and benzoxazine derivatives as progesterone receptor modulators |
| 01/30/2002 | EP1175403A1 6,7-disubstituted-5,8-quinolinedione derivatives as an antifungal agent |
| 01/30/2002 | EP0944600B1 Process for converting hydroxy heteroaromatics to arylamines |
| 01/30/2002 | EP0937044B1 Cftr channel activator compounds and pharmaceutical compositions containing same |
| 01/30/2002 | EP0863876B1 Quinoline derivatives containing a diol as leukotriene antagonists |
| 01/30/2002 | EP0740689B1 Substituted unsymmetrical cyanine dyes with selected permeability |
| 01/30/2002 | CN1333769A Thiourea inhibitors of herps viruses |
| 01/30/2002 | CN1333765A Cycloalkyl-substituted aminomethylpyrrolidine derivatives |
| 01/30/2002 | CN1333758A Substituted bicyclic derivatives useful as anticancer agents |
| 01/30/2002 | CN1333753A Quinolinecarboxamides as antiviral agents |
| 01/30/2002 | CN1333752A Process for producing quinolinecarbaldehyde |
| 01/30/2002 | CN1333750A Acetamide and substituted acetamide-containing thiourea inhibitors of herpes viruses |
| 01/29/2002 | US6342633 O-benzyl oxime ether derivatives and their use as pesticides |
| 01/29/2002 | US6342602 Bind specifically or selectively to rar-alpha receptors |
| 01/29/2002 | US6342508 N-hydroxy-2-(Alkyl,Aryl or Heteroaryl sulfanyl, sulfinyl or sulfonyl) 3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors |
| 01/29/2002 | US6342379 Detection of transmembrane potentials by optical methods |
| 01/24/2002 | WO2002006189A2 Aniline derivatives |